NRP1 and cancer: A main difference could be the lack of NRP-1 expression on the MC38 cancer cells, suggesting that the anti-tumor effect in this model is due to the blockade of NRP-1 on immune cells, of which myeloid cells showed the highest NRP-1 expression in MC38 tumors.